Correlation Between Verrica Pharmaceuticals and Climb Bio
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Climb Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Climb Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Climb Bio, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Climb Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Climb Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Climb Bio.
Diversification Opportunities for Verrica Pharmaceuticals and Climb Bio
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Verrica and Climb is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Climb Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Climb Bio and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Climb Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Climb Bio has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Climb Bio go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Climb Bio
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to under-perform the Climb Bio. But the stock apears to be less risky and, when comparing its historical volatility, Verrica Pharmaceuticals is 1.79 times less risky than Climb Bio. The stock trades about -0.4 of its potential returns per unit of risk. The Climb Bio is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest 302.00 in Climb Bio on October 7, 2024 and sell it today you would lose (77.00) from holding Climb Bio or give up 25.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Climb Bio
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Climb Bio |
Verrica Pharmaceuticals and Climb Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Climb Bio
The main advantage of trading using opposite Verrica Pharmaceuticals and Climb Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Climb Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Climb Bio will offset losses from the drop in Climb Bio's long position.| Verrica Pharmaceuticals vs. Mustang Bio | Verrica Pharmaceuticals vs. Moleculin Biotech | Verrica Pharmaceuticals vs. Medicus Pharma Ltd | Verrica Pharmaceuticals vs. Madrigal Pharmaceuticals |
| Climb Bio vs. Vaccinex | Climb Bio vs. Vincerx Pharma | Climb Bio vs. Viracta Therapeutics | Climb Bio vs. Dogwood Therapeutics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |